VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
- PMID: 29737375
- PMCID: PMC11028124
- DOI: "V体育2025版" 10.1007/s00262-018-2169-1
VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
Abstract
Adaptive immune responses contribute to the pathogenesis of melanoma by facilitating immune evasion. V-domain Ig suppressor of T-cell activation (VISTA) is a potent negative regulator of T-cell function and is expressed at high levels on monocytes, granulocytes, and macrophages, and at lower densities on T-cell populations within the tumor microenvironment. In this study, 85 primary melanoma specimens were selected from pathology tissue archives and immunohistochemically stained for CD3, PD-1, PD-L1, and VISTA. Pearson's correlation coefficients identified associations in expression between VISTA and myeloid infiltrate (r = 0. 28, p = 0. 009) and the density of PD-1+ inflammatory cells (r = 0. 31, p = 0. 005). The presence of VISTA was associated with a significantly worse disease-specific survival in univariate analysis (hazard ratio = 3. 57, p = 0. 005) and multivariate analysis (hazard ratio = 3. 02, p = 0. 02). Our findings show that VISTA expression is an independent negative prognostic factor in primary cutaneous melanoma and suggests its potential as an adjuvant immunotherapeutic intervention in the future. VSports手机版.
Keywords: Checkpoint inhibitor; Melanoma; Survival; Tumor microenvironment; Tumor-infiltrating lymphocytes; VISTA. V体育安卓版.
Conflict of interest statement
Randolph J. Noelle is the co-founder of ImmuNext. All other authors declare no conflicts of interest V体育ios版.
Figures
References
-
- Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in the cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S17–S25. - V体育安卓版 - PubMed
-
- Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622–3634. doi: 10.1200/JCO.2001.19.16.3622. - VSports - DOI - PubMed
-
- Clemente CG, Mihm MC, Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303–1310. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>V体育ios版 - 3.0.CO;2-5. - DOI - PubMed
MeSH terms
- "VSports app下载" Actions
- VSports最新版本 - Actions
- Actions (VSports手机版)
- VSports app下载 - Actions
- V体育官网 - Actions
- Actions (VSports手机版)
- VSports在线直播 - Actions
- "VSports在线直播" Actions
Substances
- "V体育平台登录" Actions
- V体育ios版 - Actions
- "VSports最新版本" Actions
- Actions (V体育官网)
Grants and funding
"V体育官网入口" LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
